My backgound
A native of Berlin, Germany, I am a business management consultant who moved to the United States soon after the Berlin Wall crumbled in 1989.
I led a fast-growing technology company before being recruited to drive a new start-up venture in late 1999, serving for seven years as co-founder and chief executive of the health services company MediGuide. During this time I led its successful business development initiatives in the United States, Europe and the Asia-Pacific region.
I served as President of Freeh Group International Solutions, a global risk management firm founded by former FBI Director Louis Freeh to assist multinational corporations with corporate governance, compliance and high-level security needs.
The National Association of Corporate Directors (NACD) has awarded me its highest credential of Board Leadership Fellow® for eight years in a row, named me to the Commission on the Future of the American Boardroom, and has invited me as a speaker and author on emerging corporate governance, multicultural management, and global compliance issues at many of its conferences.
I also served as a non-executive director and Chairman of the Supervisory Board of International Assistance Group (IAG), a Paris-based alliance of independent medical, travel and security assistance companies with offices in more than 40 countries around the world. I am Chairman of the Board of PT AA International Indonesia, a Jakarta-based company that offers a wide range of services in the healthcare and insurance industries that is part of Across Asia Assist. In a return to my native Berlin, I am also a global business advisor to Germany’s largest startup ecosystem Factory Berlin, a next-generation business club fostering innovation.
My commitment to advanced cyber security oversight at the board level is demonstrated by my CERT Cyber Security Oversight accreditation from the National Association of Corporate Directors (NACD), Ridge Global, and Carnegie Mellon University.
Following my personal passions, I served as Chair of the American Cancer Society’s national Board of Directors in 2022 and, in 2020 and 2021 co-chaired the national search that led to the first woman becoming CEO of this 107-year-old organization. In March of 2023 I was named CEO of Epi One, a biotech startup that is on a mission to build a revolutionary cancer diagnosis platform to solve the challenge of early cancer prognosis and detection.
In January of 2022, President Biden appointed me to serve on the U.S. Commission for the Preservation of America’s Heritage Abroad.
